Rheumatoid Arthritis Prevention: catalysing PlatfORm Trial delivery (RAPPORT)

Rheumatoid Arthritis Prevention: catalysing PlatfORm Trial delivery (RAPPORT)

Background Rheumatoid arthritis is a chronic disease of immune dysregulation affecting 1% of United Kingdom adults at an estimated cost to the taxpayer exceeding £5B per annum. Recently, enhanced pathophysiological understanding and a growing array of rational therapeutic candidates have converged o...

Full description

Saved in:
Bibliographic Details
Main Authors: Michelle Bardgett, Marie Falahee, Gwenda Simons, John D Isaacs, Luke Ouma, James MS Wason, Arthur G Pratt
Format: Article
Language:English
Published: NIHR Journals Library 2025-02-01
Series:Efficacy and Mechanism Evaluation
Subjects:
platform trial
at-risk rheumatoid arthritis
operational challenges
european
stratified
biomarkers
Online Access:https://doi.org/10.3310/ASHG1864
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.3310/ASHG1864

Similar Items